| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.18 | 8e-09 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.16 | 2e-07 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | 0.18 | 3e-07 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.17 | 8e-07 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.14 | 1e-06 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.14 | 2e-06 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-06 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | 0.14 | 1e-05 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.14 | 1e-05 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.13 | 2e-05 |